Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in man
- 180 Downloads
Topical anti-inflammatory (cutaneous “vasoconstriction”) and systemic glucocorticoid (depression of plasma cortisol and changes in differential WBC count) potencies of the two glucocorticoids budesonide and beclomethasone dipropionate (BDP) were compared in human volunteers. After topical application, budesonide was 2–3 times more potent than BDP in inducing “vasoconstriction”. After oral administration, on the other hand, budesonide was 2–4 times less potent than BDP in depressing plasma cortisol and changing the total or differential WBC. After inhalation, too, significant differences in favour of budesonide were noted, but the divergence between the drugs was less pronounced. The improved relationship between the topical and systemic glucocorticoid effects of budesonide makes it a promising alternative for aerosol treatment in asthma.
Key wordsbeclomethasone diproprionate budesonide glucocorticoids aerosol plasma cortisol differential WBC topical effect topical administration
Unable to display preview. Download preview PDF.
- Armitage P (1974) Statistical methods in clinical research. Blackwell, OxfordGoogle Scholar
- Björkander J, Formgren H, Johansson SÅ, Millquist E (1982) Methodological aspects on clinical trials with inhaled corticosteroids: Results of two comparisons between two steroid aerosols in patients with asthma. Eur J Respir Dis Suppl 122 (Vol 63) 108–117Google Scholar
- Buniva G, Dubini A, Sassella D (1979) Human bioassay of corticotropin-suppressing eosinopenic and hyperglycaemic potencies of deflazacort and prednisone. Curr Ther Res 26: 69–81Google Scholar
- Finney DJ (1952) Statistical method in biological assay. Hafner, New YorkGoogle Scholar
- Harris DM (1980) In: Topical steroid treatment for asthma and rhinitis. Clark THJ and Mygind N (eds) Clinical Pharmacology of Beclomethasone dipropionate. Baillere-Tindall, London, pp 34–47Google Scholar
- McKenzie AW, Stoughton RB (1962) Method for comparing percutaneous absorption of steroids. Arch Dermatol 86: 608–610Google Scholar
- Rosenhall L, Lundquist G, Ädelroth E, Glennow C (1982) Comparison between inhaled and oral corticosteroids in patients with chronic asthma. Eur J Respir Dis Suppl 122 (Vol 63) 154–162Google Scholar
- Ryrfeldt Å, Andersson P, Edsbäcker S, Tönnesson M, Davies D, Pauwels R (1981) Pharmacokinetics of a selective glucocorticoid, budesonide. Proceedings of the Annual Meeting of European Academy of Allergology and Clinical Immunology, Clermont-Ferrand, France 704–708Google Scholar
- Thalén A, Brattsand R (1979) Synthesis and Anti-inflammatory properties of budesonide, a new non-halogenated glucocorticoid with high local activity. Arzneim Forsch 29 (II), 11: 1687–1690Google Scholar
- Toogood JH, Lefcoe NH, Haines DSM, Jennings B, Errington M, Baksh L, Chuang L (1977a) A graded doseassessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma. J Allergy 59: 298–308Google Scholar
- Toogood JH, Lefcoe NH, Haines DSM, Chuang L, Jennings B, Errington N, Baksh L, Cauchi M (1978) Minimum dose requirements of steroid-dependent asthmatic patients for aerosol beclomethasone and oral prednisone. J Allergy 61: 355–364Google Scholar